πŸ‡ΊπŸ‡Έ FDA
Patent

US 10584337

Modulatory polynucleotides

granted A61PA61P43/00

Quick answer

US patent 10584337 (Modulatory polynucleotides) held by VOYAGER THERAPEUTICS, INC. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P43/00